Literature DB >> 18425796

Botulinum toxin for recurrent anal fissure following lateral internal sphincterotomy.

G Brisinda1, F Cadeddu, F Brandara, G Marniga, S Vanella, C Nigro, G Maria.   

Abstract

BACKGROUND: The aim of the study was to evaluate the efficacy of botulinum toxin injection in the treatment of recurrent anal fissure following lateral internal sphincterotomy.
METHODS: Eighty patients were treated with botulinum toxin (30 units Botox or 90 units Dysport), injected into two sites of the internal sphincter. Clinical and manometric results were recorded before and after treatment. If symptoms persisted at 2 months, the examiners could decide to re-treat the patient. The same preparation of serotype A of botulinum neurotoxin was used for reinjection.
RESULTS: One month after injection there was complete healing in 54 patients (68 per cent). Eight patients (10 per cent) reported mild incontinence of flatus that had disappeared spontaneously within 2 months. At 2 months, 59 patients (74 per cent) had a healing scar. After reinjection, 11 of 21 re-treated patients reported mild incontinence to flatus that lasted for a few weeks and resolved spontaneously. Anorectal manometry at 1 month demonstrated a significant reduction in both resting anal pressure and maximum voluntary squeeze pressure (P < 0.001). There were no relapses during a mean value of 57.9 months of follow-up.
CONCLUSION: Botulinum toxin is efficacious in patients with recurrent anal fissure following lateral internal sphincterotomy. 2008 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18425796     DOI: 10.1002/bjs.6080

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  Advancement flap in the management of chronic anal fissure: a prospective study.

Authors:  Rosalia Patti; Giovanni Guercio; Valentina Territo; Paolo Aiello; Giuseppe Livio Angelo; Gaetano Di Vita
Journal:  Updates Surg       Date:  2012-04-10

2.  Anal fissure.

Authors:  Karen N Zaghiyan; Phillip Fleshner
Journal:  Clin Colon Rectal Surg       Date:  2011-03

Review 3.  Endoscopy in the diagnosis and management of motility disorders.

Authors:  Yael Kopelman; George Triadafilopoulos
Journal:  Dig Dis Sci       Date:  2011-02-01       Impact factor: 3.199

4.  Chronic anal fissure: Surgical or reversible neurochemical sphincterotomy?

Authors:  Giuseppe Brisinda; Serafino Vanella
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-12       Impact factor: 46.802

5.  Gastrointestinal Uses of Botulinum Toxin.

Authors:  Maria Cariati; Maria Michela Chiarello; Marco Cannistra'; Maria Antonietta Lerose; Giuseppe Brisinda
Journal:  Handb Exp Pharmacol       Date:  2021

6.  Fissurectomy combined with anoplasty and injection of botulinum toxin in treatment of anterior chronic anal fissure with hypertonia of internal anal sphincter: a pilot study.

Authors:  R Patti; F Famà; A Tornambè; G Asaro; G Di Vita
Journal:  Tech Coloproctol       Date:  2010-02-03       Impact factor: 3.781

7.  Pharmacological sphincterotomy for chronic anal fissures by botulinum toxin a.

Authors:  Uwe Wollina
Journal:  J Cutan Aesthet Surg       Date:  2008-07

Review 8.  Treatment of gastrointestinal sphincters spasms with botulinum toxin A.

Authors:  Giuseppe Brisinda; Nicola Sivestrini; Giuseppe Bianco; Giorgio Maria
Journal:  Toxins (Basel)       Date:  2015-05-29       Impact factor: 4.546

9.  Fisurectomy and anoplasty with botulinum toxin injection in patients with chronic anal posterior fissure with hypertonia: a long-term evaluation.

Authors:  Beatrice D'Orazio; Girolamo Geraci; Guido Martorana; Carmelo Sciumé; Giovanni Corbo; Gaetano Di Vita
Journal:  Updates Surg       Date:  2020-07-14

Review 10.  Benign anorectal disease: hemorrhoids, fissures, and fistulas.

Authors:  Ivy H Gardner; Ragavan V Siddharthan; Vassiliki Liana Tsikitis
Journal:  Ann Gastroenterol       Date:  2019-11-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.